| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-07 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-06 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-05 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.18 | 0.0002 |